Europe Healthcare Cold Chain Logistics Market Size
| Study Period | 2020-2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 10.40 Billion |
| Market Size (2029) | USD 16.39 Billion |
| CAGR (2024 - 2029) | 9.69 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Healthcare Cold Chain Logistics Market Analysis
The Europe Healthcare Cold Chain Logistics Market size is estimated at USD 10.40 billion in 2024, and is expected to reach USD 16.39 billion by 2029, growing at a CAGR of 9.69% during the forecast period (2024-2029).
A surge in the development and production of biopharmaceutical vaccines and advanced therapies, technological advancement, and the region's interest in R&D have contributed significantly to the market's growth.
During the COVID-19 pandemic, the pharmaceutical industry was one of the most affected sectors, witnessing increased production and supply of vaccines and antidotes worldwide. The United States Department of Transport selected 41 projects to receive around USD 653 million in grants under the Port Infrastructure Development Programme for infrastructure spending for ports and waterways in 2021. Improved temperature-controlled storage facilities at ports for pharmaceutical and other medical products, which require special temperature conditions throughout their journey, were crucial.
The European Medical Agency approves an average of 38 drugs annually, depicting an increase in the development of biopharmaceuticals. The growth in the biopharmaceuticals sector demands advanced requirements for the storage and supply of the products, as regulatory compliance and patient safety are manufacturers' primary concerns.
In 2023, Germany spent USD 8,011 per capita on health, approximately 12.7% of GDP. It is also one of the largest producers and exporters of healthcare products.
Europe Healthcare Cold Chain Logistics Market Trends
The OTC Pharmaceuticals Consumption is Projected to Grow Significantly
A notable increase in health awareness among consumers in Europe has been noticed during the pandemic. By empowering people and making better ways of accessing healthcare, self-care has the potential to meet these challenges. The growth of European healthcare cold chain logistics is a result of these reasons.
People are looking proactively for ways to manage their health, which has led to a growth in the demand for self-care and OTC pharmaceuticals. Consequently, OTC pharmaceutical consumption in Europe has become more accessible to consumers as a result of the development of e-commerce platforms. The growth of this segment can be attributed to the convenience of individuals buying healthcare products through electronic platforms. As per industry experts, in 2023, OTC pharmaceuticals consumption increased from USD 50.46 billion in 2022 to USD 52.72 billion in 2023 and is projected to reach USD 54.79 billion in 2024.
Governments across the region are also supporting market players. For instance, in November 2023, the Swedish Government expanded the use of naloxone spray that reverses opioid overdose. To offer a wider range of medicines for common illnesses such as pain relief, cough and cold, allergies, digestive disorders, and more, pharmaceutical companies in Europe are expanding their OTC product portfolio. As a result, stringent and efficient cold chain logistics systems are increasingly in demand.
Germany is Set to Lead Pharmaceuticals Production
In 2022, pharmaceutical production in Germany was valued at its highest at EUR 37.4 billion (USD 40.31 billion). According to Strategy 4.0, published in November 2023, the German Government is also discussing a new Pharma Strategy with a number of reforms to improve the conditions for the pharmaceutical industry in Germany.
The increase in pharmaceutical production is due to the growing instances of chronic diseases and increased emphasis on prevention and self-medication for disease. In addition, the country's growth has been driven by an increase in the use of OTC medicines.
In addition, government support for research and development helps speed up the development of medicines. In 2022, according to a 2023 article published by Eurostat, across the EU, the total government budget allocations for R&D (GBARD) stood at EUR 117.37 billion (USD 126.52 billion), equivalent to 0.74% of GDP. An increase of 5.4% compared with 2021.
Europe Healthcare Cold Chain Logistics Industry Overview
The market for healthcare cold chain logistics in Europe is competitive, owing to the presence of various companies. The healthcare cold chain logistics industry in Europe may have high barriers to entry due to the need for specialized infrastructure, temperature-controlled storage facilities, and compliance with stringent regulatory requirements. To be competitive efficiently, newcomers would need to invest significantly in technology, expertise, and facilities. New entrants face the challenge of stringent regulations and compliance standards, including guidelines on Good Distribution Practice (GDP) guidelines. The primary growth tactics used by businesses to maintain their competitiveness are the integration of technologies, worldwide network expansion, and modernization of cold storage centers. Several European healthcare cold chain logistics market players are headquartered in Germany, such as DB Schenker and Rhenus Logistics. DHL International Gmbh and Kuehne + Nagel are among the most important players in this sector.
Europe Healthcare Cold Chain Logistics Market Leaders
DHL
Carrier Transicold
Kuehne + Nagel
DB Schenker
PrimaFrio
*Disclaimer: Major Players sorted in no particular order
Europe Healthcare Cold Chain Logistics Market News
February 2024: United Parcel Service (UPS) purchased the healthcare logistics division of Transports (Chabas Santé) to expand its global healthcare network, offering temperature-controlled transportation solutions for pharmaceuticals and healthcare products in the south of France. UPS Healthcare will add 50 team members, more than 40 temperature-controlled vehicles, and warehousing facilities.
November 2023: Maersk began the construction of a new cold store in Rotterdam, The Netherlands. The specialized warehouse is situated in proximity to the Maasvlakte II terminal operated by APM Terminals, set to be operational by early 2025. The new facility is said to have a capacity greater than 40 Feet Equivalent Units, making it a key component of Maersk’s integrated logistics offering for its customers across North-West Europe.
Europe Healthcare Cold Chain Logistics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS
4.1 Current Market Scenario
4.2 Technological Trends
4.3 Industry Value Chain Analysis
4.4 Government Regulations and Initiatives
4.5 Spotlight on Ambient/Temperature-controlled Storage
4.6 Insights into Refrigerants and Packaging Materials Used in Refrigerated Warehouses
4.7 Impact of COVID-19 on the Market
5. MARKET DYNAMICS
5.1 Drivers
5.1.1 Increasing Focus on Vaccine Distribution
5.1.2 Growing Pharmaceutical and Biotechnology Industries
5.2 Restraints
5.2.1 High Initial Capital Investment
5.2.2 Risk of Temperature Excursions
5.3 Opportunities
5.3.1 E-commerce Growth in Healthcare
5.4 Industry Attractiveness - Porter's Five Forces Analysis
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Consumers / Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitute Products
5.4.5 Intensity of Competitive Rivalry
6. MARKET SEGMENTATION
6.1 By Product
6.1.1 Biopharmaceuticals
6.1.2 Vaccines
6.1.3 Clinical Trial Materials
6.2 By Services
6.2.1 Transportation
6.2.2 Storage
6.2.3 Value Added Services (Packaging and Labeling)
6.3 By End User
6.3.1 Hospitals, Clinics and Pharmaceuticals
6.3.2 Biopharmaceutical
6.3.3 Biotechnology
6.4 By Country
6.4.1 Germany
6.4.2 France
6.4.3 Spain
6.4.4 Rest of Europe
7. COMPETITIVE LANDSCAPE
7.1 Overview (Market Concentration and Major Players)
7.2 Company Profiles
7.2.1 Carrier Transicold
7.2.2 Primafrio
7.2.3 Alloga
7.2.4 Kuehne + Nagel
7.2.5 Cavalier Logistics
7.2.6 Marken Ltd
7.2.7 Biocair
7.2.8 DB Schenker
7.2.9 DHL
7.2.10 Envirotainer*
- *List Not Exhaustive
7.3 Other Companies
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
9. APPENDIX
Europe Healthcare Cold Chain Logistics Industry Segmentation
Healthcare cold chain logistics services involve specialized solutions for secured storage, transport, and distribution of temperature-sensitive healthcare products, such as pharmaceuticals and vaccines. These services include temperature-controlled transportation with advanced packaging, cold storage facilities, real-time monitoring for supply chain visibility, risk management, and specialized handling for biopharmaceuticals. The complete offerings ensure the efficacy of healthcare products, along with regulatory guidelines.
A comprehensive background analysis of the European healthcare cold chain logistics market covers current market trends, restraints, technological updates, and detailed information on various segments and the industry's competitive landscape. The impact of COVID-19 has also been incorporated and considered during the study.
Europe's healthcare cold chain logistics market is segmented by product (biopharmaceuticals, vaccines, and clinical trial materials), services (transportation, storage, packaging, and value-added services (packaging and labeling), end user (hospitals, clinics, and pharmaceuticals, biopharmaceutical, and biotechnology) and country (Germany, France, Italy, Spain, and Rest of Europe).The report offers market size and forecasts for the European healthcare cold chain logistics market in value (USD) for all the above segments.
| By Product | |
| Biopharmaceuticals | |
| Vaccines | |
| Clinical Trial Materials |
| By Services | |
| Transportation | |
| Storage | |
| Value Added Services (Packaging and Labeling) |
| By End User | |
| Hospitals, Clinics and Pharmaceuticals | |
| Biopharmaceutical | |
| Biotechnology |
| By Country | |
| Germany | |
| France | |
| Spain | |
| Rest of Europe |
Europe Healthcare Cold Chain Logistics Market Research FAQs
How big is the Europe Healthcare Cold Chain Logistics Market?
The Europe Healthcare Cold Chain Logistics Market size is expected to reach USD 10.40 billion in 2024 and grow at a CAGR of 9.69% to reach USD 16.39 billion by 2029.
What is the current Europe Healthcare Cold Chain Logistics Market size?
In 2024, the Europe Healthcare Cold Chain Logistics Market size is expected to reach USD 10.40 billion.
Who are the key players in Europe Healthcare Cold Chain Logistics Market?
DHL, Carrier Transicold, Kuehne + Nagel, DB Schenker and PrimaFrio are the major companies operating in the Europe Healthcare Cold Chain Logistics Market.
What years does this Europe Healthcare Cold Chain Logistics Market cover, and what was the market size in 2023?
In 2023, the Europe Healthcare Cold Chain Logistics Market size was estimated at USD 9.39 billion. The report covers the Europe Healthcare Cold Chain Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Europe Healthcare Cold Chain Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Healthcare Cold Chain Logistics Industry Report
Statistics for the 2024 Europe Healthcare Cold Chain Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Healthcare Cold Chain Logistics analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
